Brukinsa (zanubrutinib)
pCPA File Number:
22458
Negotiation Status:
Concluded with an LOI
Indication(s):
For the treatment of adult patients with chronic lymphocytic leukemia (CLL).
Sponsor/Manufacturer:
BeiGene, Ltd.
CADTH Project Number:
PC0310
pCPA Engagement Letter Issued:
Negotiation Process Concluded: